entertainment -WSS

entertainment

author：leisure time 2025-10-02 10:48:35 - browse：359

Stock exchange — Drew Angerer/Getty Images

Sage Therapeutics said Monday that it may need to reduce costs, including through employee layoffs, following the Food and Drug Administration’s denial of its rapid-acting drug for major depressive disorder.

On Friday, the agency granted market clearance for the drug, called Zurzuvae, to treat women with postpartum depression, a smaller commercial market. Sage failed to convince regulators to also approve the drug for depression, a broader condition.

“We don’t agree with the FDA review,” Sage CEO Barry Greene said during an earnings call, a point he made repeatedly. “We are evaluating the [FDA’s response letter] and as soon as we can provide more clarity, we will, on what the next steps are.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Cigna, Humana reportedly in talks to merge

knowledge

explore

WSS

Congress gives doctors Medicare pay bump

A Q&A with Aletha Maybank, AMA’s chief health equity officer

Fetal surgery at risk from Dobbs and new abortion restrictions

RaDonda Vaught to speak at CommonSpirit event on patient safety

Congress gives doctors Medicare pay bump

A Q&A with Aletha Maybank, AMA’s chief health equity officer

explore

entertainment

knowledge

DIEP, the 'gold standard' of breast reconstruction, is under threat

FDA investigates CAR

State Dept. review finds Biden bears some blame for Afghanistan failures

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

What to do when lifesaving products contribute to climate change

Cancer drug shortages should be causing more outrage

FogPharma raises $145 million in rare Series E round

Cancer drug shortages should be causing more outrage

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

knowledge

Congress gives doctors Medicare pay bump

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

FDA investigates CAR

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

How to pay for weight loss drugs and save Medicare

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

knowledge

knowledge

explore

Wikipedia